» Articles » PMID: 36681665

Time-resolved RNA Signatures of CD4+ T Cells in Parkinson's Disease

Abstract

Parkinson's disease (PD) emerges as a complex, multifactorial disease. While there is increasing evidence that dysregulated T cells play a central role in PD pathogenesis, elucidation of the pathomechanical changes in related signaling is still in its beginnings. We employed time-resolved RNA expression upon the activation of peripheral CD4+ T cells to track and functionally relate changes on cellular signaling in representative cases of patients at different stages of PD. While only few miRNAs showed time-course related expression changes in PD, we identified groups of genes with significantly altered expression for each different time window. Towards a further understanding of the functional consequences, we highlighted pathways with decreased or increased activity in PD, including the most prominent altered IL-17 pathway. Flow cytometric analyses showed not only an increased prevalence of Th17 cells but also a specific subtype of IL-17 producing γδ-T cells, indicating a previously unknown role in PD pathogenesis.

Citing Articles

Gut-first Parkinson's disease is encoded by gut dysbiome.

Munoz-Pinto M, Candeias E, Melo-Marques I, Esteves A, Maranha A, Magalhaes J Mol Neurodegener. 2024; 19(1):78.

PMID: 39449004 PMC: 11515425. DOI: 10.1186/s13024-024-00766-0.


Comprehensive data for studying serum exosome microRNA transcriptome in Parkinson's disease patients.

Yu Z, Saiki S, Shiina K, Iseki T, Sasazawa Y, Ishikawa K Sci Data. 2024; 11(1):1128.

PMID: 39406833 PMC: 11480472. DOI: 10.1038/s41597-024-03909-6.


The miRNA-target interactions: An underestimated intricacy.

Diener C, Keller A, Meese E Nucleic Acids Res. 2023; 52(4):1544-1557.

PMID: 38033323 PMC: 10899768. DOI: 10.1093/nar/gkad1142.


Uncovering ferroptosis in Parkinson's disease via bioinformatics and machine learning, and reversed deducing potential therapeutic natural products.

Wang P, Chen Q, Tang Z, Wang L, Gong B, Li M Front Genet. 2023; 14:1231707.

PMID: 37485340 PMC: 10358855. DOI: 10.3389/fgene.2023.1231707.

References
1.
HOEHN M, Yahr M . Parkinsonism: onset, progression and mortality. Neurology. 1967; 17(5):427-42. DOI: 10.1212/wnl.17.5.427. View

2.
Bolte A, Lukens J . Th17 Cells in Parkinson's Disease: The Bane of the Midbrain. Cell Stem Cell. 2018; 23(1):5-6. PMC: 7839142. DOI: 10.1016/j.stem.2018.06.016. View

3.
Szklarczyk D, Gable A, Nastou K, Lyon D, Kirsch R, Pyysalo S . The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2020; 49(D1):D605-D612. PMC: 7779004. DOI: 10.1093/nar/gkaa1074. View

4.
Sommer A, Marxreiter F, Krach F, Fadler T, Grosch J, Maroni M . Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease. Cell Stem Cell. 2018; 23(1):123-131.e6. DOI: 10.1016/j.stem.2018.06.015. View

5.
OBrien R, Roark C, Born W . IL-17-producing gammadelta T cells. Eur J Immunol. 2009; 39(3):662-6. PMC: 2698711. DOI: 10.1002/eji.200839120. View